创伤后静脉血栓栓塞症的研究优先事项:国家创伤研究行动计划二次分析
该研究为对国家创伤研究行动计划11个德尔菲专家小组共识研究优先事项数据库的二次分析,检索关键词VTE、venous thromboembo和DVT后归类。共识别出86个VTE相关研究问题,分布于9个专家小组;85个问题达成共识,其中24个评为高优先级、60个为中优先级、1个为低优先级。问题最常见涉及VTE预防时机(n=17),其次为VTE发生危险因素(n=16)、氨甲环酸对VTE的影响(n=11)、药物预防给药方案(n=8)和药物预防药物选择(n=6)。作者结论认为这些共识研究问题应推动专项院外研究资助以支持优化创伤后VTE预防的质量研究。
要点
- 85个VTE相关研究问题达成共识,24个高优先级、60个中优先级、1个低优先级。
- 最常见研究问题为VTE预防时机(n=17),其次为VTE发生危险因素(n=16)。
- 氨甲环酸对VTE的影响相关问题有11个,药物预防给药方案问题8个,药物选择问题6个。
- 86个VTE相关研究问题分布于9个国家创伤研究行动计划专家小组。
- 证据等级为预后与流行病学;Level IV。
研究设计与关键结果
- 研究类型:对国家创伤研究行动计划11个德尔菲专家小组共识研究优先事项数据库的二次分析。
- 共识别出86个VTE相关研究问题,分布于9个NTRAP专家小组;85个问题达成共识,其中24个高优先级、60个中优先级、1个低优先级。
- 问题主题分布:VTE预防时机n=17、VTE发生危险因素n=16、氨甲环酸对VTE的影响n=11、药物预防给药方案n=8、药物预防药物选择n=6。
证据类型、等级与局限
- 证据类型:德尔菲法共识研究优先事项的二次分析;证据等级:预后与流行病学;Level IV。
- 局限:原文未报告局限性
对床旁实践的改变
- 原文未据此给出推荐;作者结论认为这些共识研究问题应推动专项院外研究资助以支持优化创伤后VTE预防的质量研究。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「适用人群与场景」「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Venous thromboembolism (VTE) is a significant cause of morbidity and mortality during recovery from injury and can result in significant health care costs. Despite advances in the past several decades in our approach to VTE prophylaxis after injury, opportunities exist to improve the delivery and implementation of optimal VTE prophylaxis. Here, we aim to identify consensus research questions related to VTE across all National Trauma Research Action Plan (NTRAP) Delphi expert panels to further guide the research agenda aimed at preventing VTE after injury.
METHODS: This is a secondary analysis of consensus-based research priorities that were collected using a Delphi methodology by 11 unique NTRAP panels that were charged with unique topic areas across the spectrum of injury care. The database of questions was queried for the keywords "VTE," "venous thromboembo," and "DVT" and then grouped into relevant topic areas.
RESULTS: There were 86 VTE-related research questions identified across 9 NTRAP panels. Eighty-five questions reached consensus with 24 rated high priority; 60, medium priority; and 1, low priority. Questions related to the timing of VTE prophylaxis (n = 17) were most common, followed by questions related to risk factors for the development of VTE (n = 16), the effects of tranexamic acid on VTE (n = 11), the approach to dosing of pharmacologic prophylaxis (n = 8), and the pharmacologic prophylactic medication choice for optimal VTE prophylaxis (n = 6).
CONCLUSION: National Trauma Research Action Plan panelists identified 85 consensus-based research questions that should drive dedicated extramural research funding opportunities to support quality studies aimed at optimizing VTE prophylaxis after injury.
LEVEL OF EVIDENCE: Prognostic and Epidemiological; Level IV.
参考来源
- Costantini TW, Bulger E, Price MA, et al. Research priorities in venous thromboembolism after trauma: Secondary analysis of the National Trauma Research Action Plan. J Trauma Acute Care Surg. 2023. PMID: 37322589. doi:10.1097/TA.0000000000004074
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。